<DOC>
	<DOCNO>NCT01294410</DOCNO>
	<brief_summary>The purpose study determine whether BMS-936557 effective treatment moderate severely active ulcerative colitis patient insufficient response and/or intolerance medical therapy ulcerative colitis</brief_summary>
	<brief_title>Induction Maintenance Study BMS-936557 Patients With Moderate Severe Ulcerative Colitis</brief_title>
	<detailed_description />
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Colitis , Ulcerative</mesh_term>
	<mesh_term>Colitis</mesh_term>
	<mesh_term>Antibodies</mesh_term>
	<mesh_term>Immunoglobulins</mesh_term>
	<criteria>Clinical diagnosis moderate severe UC confirm endoscopic histologic evidence Mayo score ≥6 endoscopic subscore ≥2 Inadequate response and/or intolerance one conventional therapy ( i.e . oral aminosalicylates , immunosuppressant , corticosteroid , and/or TNF antagonist ) Diagnosis Crohn 's Disease Indeterminate Colitis Diagnosis UC limit rectum Evidence fulminant colitis , toxic megacolon , bowel perforation Current need colostomy ileostomy Previous total subtotal colectomy</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2015</verification_date>
</DOC>